As one of Asia’s established biotechnology groups, BIONET Group integrates three core companies: BIONET Corp., GGA Corp., and BIONET Therapeutics Corp. Although each company focuses on a different area of biotechnology, they share the same scientific foundation, research capabilities, quality standards, and commitment to innovation — forming a unified “One BIONET” platform.
About BIONET Group
BIONET Group is a Taiwan-based biotechnology group established in 1999, with nearly 30 years of experience in genetic testing, precision health, regenerative medicine, cell technology, exosome research, and AI-driven biotechnology innovation. BIONET Group has expanded our services to multiple international markets and served more than 1.8 million customers worldwide.
One BIONET Platform
Our Core Companies
BIONET Corp.
Cord Blood Banking, Stem Cell
and Cell Technology
Established in 1999, BIONET Corp. is Taiwan's first publicly listed stem cell company and pioneer of Taiwan’s first stem cell storage brand. It launched Asia’s first umbilical cord mesenchymal stem cell storage service. Key services include cord blood stem cell banking, stem cell storage and immune cell-related services.
GGA Corp.
Genetic Testing, Precision Health
and Digital Technology
Established in 2008, GGA Corp. is Taiwan's first publicly listed company specialising in precision health and digital technology. It provides genetic testing solutions across different life stages, including preconception, maternal-fetal medicine, newborn health, paediatric disease diagnosis and AI-powered laboratory applications.
BIONET Therapeutics Corp.
Exosome Technology, AI-Driven
R&D and Cell-Based Innovation
Established in 2022, BIONET Therapeutics Corp. focuses on exosome technology and AI-driven R&D. It develops AI Exosome Foundry platforms for screening, purification and production optimisation, while supporting formulation development, manufacturing and customised product innovation.
BIONET Group in Malaysia
In Malaysia, Genetics Generation Asia Sdn. Bhd. (GGA Malaysia) is a subsidiary of BIONET Group, serving as the Group’s local platform for genetic medicine, precision health, regenerative technology, and exosome-related biotechnology solutions.
We work closely with medical institutions, obstetricians and gynaecologists, paediatricians, fertility centres, and aesthetic professionals to bring BIONET Group’s research capabilities and technologies to the Malaysian healthcare market.
Through our services and professional support, we aim to provide healthcare professionals and consumers with reliable, science-backed, and innovative health technology solutions.
